264 related articles for article (PubMed ID: 16898895)
1. A review of the European Directive for prescribing systemic isotretinoin for acne vulgaris.
Layton AM; Dreno B; Gollnick HP; Zouboulis CC
J Eur Acad Dermatol Venereol; 2006 Aug; 20(7):773-6. PubMed ID: 16898895
[TBL] [Abstract][Full Text] [Related]
2. An expert view on the treatment of acne with systemic antibiotics and/or oral isotretinoin in the light of the new European recommendations.
Dréno B; Bettoli V; Ochsendorf F; Perez-Lopez M; Mobacken H; Degreef H; Layton A
Eur J Dermatol; 2006; 16(5):565-71. PubMed ID: 17101480
[TBL] [Abstract][Full Text] [Related]
3. US FDA Advisory Committee meetings held to discuss isotretinoin, safety issues and a new accutane formulation.
Maddin S
Skin Therapy Lett; 2000; 6(2):5. PubMed ID: 11071724
[No Abstract] [Full Text] [Related]
4. Isotretinoin prescribing: finding a balance between benefit and risk.
Stern RS
Pharmacoepidemiol Drug Saf; 2005 Sep; 14(9):611-3. PubMed ID: 16134100
[No Abstract] [Full Text] [Related]
5. Safety and side effects of the acne drug, oral isotretinoin.
Charakida A; Mouser PE; Chu AC
Expert Opin Drug Saf; 2004 Mar; 3(2):119-29. PubMed ID: 15006718
[TBL] [Abstract][Full Text] [Related]
6. Arthritis precipitated by isotretinoin treatment for acne vulgaris.
Hughes RA
J Rheumatol; 1993 Jul; 20(7):1241-2. PubMed ID: 8371229
[TBL] [Abstract][Full Text] [Related]
7. Is oral isotretinoin the treatment of choice in moderate and severe inflammatory acne vulgaris?
Verros CD; Rallis E
J Eur Acad Dermatol Venereol; 2007 Oct; 21(9):1270-1. PubMed ID: 17894728
[No Abstract] [Full Text] [Related]
8. The role of isotretinoin in acne therapy: why not as first-line therapy? facts and controversies.
Rigopoulos D; Larios G; Katsambas AD
Clin Dermatol; 2010; 28(1):24-30. PubMed ID: 20082946
[TBL] [Abstract][Full Text] [Related]
9. Management of severe acne.
Zouboulis CC; Bettoli V
Br J Dermatol; 2015 Jul; 172 Suppl 1():27-36. PubMed ID: 25597508
[TBL] [Abstract][Full Text] [Related]
10. Identification and management of oral isotretinoin use inconsistent with product labeling.
Wert S
Manag Care Interface; 2003 Mar; 16(3):41-3, 55. PubMed ID: 12715412
[TBL] [Abstract][Full Text] [Related]
11. Oral isotretinoin treatment policy. Do we all agree?
Ortonne JP
Dermatology; 1997; 195 Suppl 1():34-7; discussion 38-40. PubMed ID: 9310744
[TBL] [Abstract][Full Text] [Related]
12. Isotretinoin made S.M.A.R.T. and simple.
Lowenstein EJ
Cutis; 2002 Aug; 70(2):115-20. PubMed ID: 12234158
[TBL] [Abstract][Full Text] [Related]
13. Clinical and therapeutic approach to childhood acne: an update.
Antoniou C; Dessinioti C; Stratigos AJ; Katsambas AD
Pediatr Dermatol; 2009; 26(4):373-80. PubMed ID: 19689511
[TBL] [Abstract][Full Text] [Related]
14. Roaccutane treatment guidelines: results of an international survey.
Cunliffe WJ; van de Kerkhof PC; Caputo R; Cavicchini S; Cooper A; Fyrand OL; Gollnick H; Layton AM; Leyden JJ; Mascaró JM; Ortonne JP; Shalita A
Dermatology; 1997; 194(4):351-7. PubMed ID: 9252756
[TBL] [Abstract][Full Text] [Related]
15. Safety of a new micronized formulation of isotretinoin in patients with severe recalcitrant nodular acne: A randomized trial comparing micronized isotretinoin with standard isotretinoin.
Strauss JS; Leyden JJ; Lucky AW; Lookingbill DP; Drake LA; Hanifin JM; Lowe NJ; Jones TM; Stewart DM; Jarratt MT; Katz I; Pariser DM; Pariser RJ; Tschen E; Chalker DK; Rafal ES; Savin RP; Roth HL; Chang LK; Baginski DJ; Kempers S; McLane J; Eberhardt D; Leach EE; Bryce G; Hong J
J Am Acad Dermatol; 2001 Aug; 45(2):196-207. PubMed ID: 11464180
[TBL] [Abstract][Full Text] [Related]
16. A review of systemic retinoid therapy for acne and related conditions.
Kunynetz RA
Skin Therapy Lett; 2004 Mar; 9(3):1-4. PubMed ID: 15037925
[TBL] [Abstract][Full Text] [Related]
17. [Treatment of acne by isotretinoin (general course)].
Chivot M
Rev Prat; 2002 Apr; 52(8):845-9. PubMed ID: 12053792
[TBL] [Abstract][Full Text] [Related]
18. Isotretinoin dosing: past, present, and future trends.
Hirsch RJ; Shalita AR
Semin Cutan Med Surg; 2001 Sep; 20(3):162-5. PubMed ID: 11594671
[TBL] [Abstract][Full Text] [Related]
19. Acute acne flare following isotretinoin administration: potential protective role of low starting dose.
Borghi A; Mantovani L; Minghetti S; Virgili A; Bettoli V
Dermatology; 2009; 218(2):178-80. PubMed ID: 19060474
[No Abstract] [Full Text] [Related]
20. Isotretinoin-induced nail fragility and onycholysis.
Onder M; Oztaş MO; Oztaş P
J Dermatolog Treat; 2001 Jun; 12(2):115-6. PubMed ID: 12243670
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
